47 MOD-6031, a long-acting, pegylated molecule of oxyntomodulin, has been tested in a phase 1 single-blinded RCT (NCT02692781) on overweight or obese patients, but further investigations have not taken place
The antibodies used for the immunoblot assays were: GCLC (Santa Cruz Biotech, #sc-390811), NQO1 (Sigma Prestige Antibodies, HPA007308), ACTIN (Sigma, A1978), NRF2 (Cell Signaling Technology, #12721), NRF1 (Cell Signaling Technology, #8052), YAP/TAZ (Cell Signaling, #8418) 4-HNE (Abcam, #ab46545) and Lamin A/C (Cell Signaling, #4777)
Compounded sublingual drops have become increasingly popular as an alternative to injections
Verlengde opslag: Bewaar bij 2-8C bij opslag langer dan 6 maanden